Company intelligence / Profile preview

Zhejiang Lepu Pharmaceutical

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

Zhejiang Lepu Pharmaceutical specializes in the R&D and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms for cardiovascular disease, antibiotics/anti-infectives, oncology/cancer therapies and nervous system drugs. The company holds global regulatory certifications including CFDA for China, FDA for USA, MHRA for UK/EU GMP/COS certification for Europe/Japan/South Korea etc. Its products are widely exported with several APIs holding leading market positions globally.

Therapeutic areas: Men's HealthOncologyOtherPsychiatryDermatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Over twenty international pharmaceutical companies

Beyond the preview

Go deeper on Zhejiang Lepu Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Lepu Pharmaceutical.

Explore the full profile